The hepatopulmonary syndrome: new name, old complexities.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMC 464086)

Published in Thorax on November 01, 1992

Authors

R Rodríguez-Roisin, A G Agustí, J Roca

Articles citing this

Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med (2012) 2.33

Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut (2002) 1.40

Hyperoxia prevents exercise-induced intrapulmonary arteriovenous shunt in healthy humans. J Physiol (2008) 1.21

Hemodynamic alterations in cirrhosis and portal hypertension. Korean J Hepatol (2010) 1.18

Therapy for alcoholic liver disease. World J Gastroenterol (2014) 1.17

Hepatopulmonary Syndrome. Dig Dis Sci (2015) 1.10

Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia. World J Gastroenterol (2007) 1.05

Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat Rev Gastroenterol Hepatol (2012) 1.05

Diagnosis of hepatopulmonary syndrome with contrast transesophageal echocardiography: advantages over contrast transthoracic echocardiography. Dig Dis Sci (1999) 1.03

Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome. World J Gastroenterol (2005) 0.99

Hepatopulmonary syndrome in children with cirrhotic and non-cirrhotic portal hypertension: a single-center experience. Dig Dis Sci (2011) 0.98

Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med (1995) 0.96

Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors. World J Gastroenterol (2007) 0.96

Pilot study of pentoxifylline in hepatopulmonary syndrome. Liver Transpl (2008) 0.95

The role of garlic in hepatopulmonary syndrome: a randomized controlled trial. Can J Gastroenterol (2010) 0.95

Oxygen and 99mTc-MAA shunt estimations in patients with pulmonary arteriovenous malformations: effects of changes in posture and lung volume. Thorax (1994) 0.93

Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients. Dig Dis Sci (2003) 0.91

Cardiopulmonary complications in chronic liver disease. World J Gastroenterol (2006) 0.90

Arterial hypoxaemia in cirrhosis: fact or fiction? Gut (1998) 0.88

Viral cirrhosis: an overview of haemostatic alterations and clinical consequences. Mediterr J Hematol Infect Dis (2009) 0.85

Inflammation: a way to understanding the evolution of portal hypertension. Theor Biol Med Model (2007) 0.84

Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation. World J Gastroenterol (2006) 0.83

Pentoxifylline in hepatopulmonary syndrome. World J Gastroenterol (2012) 0.82

Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the Literature. J Clin Transl Hepatol (2016) 0.81

Spontaneous improvement in a patient with the hepatopulmonary syndrome assessed by serial exercise tests. Thorax (1994) 0.81

Arterial hypoxemia and intrapulmonary vasodilatation in rat models of portal hypertension. J Gastroenterol (2005) 0.78

Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry. BMC Gastroenterol (2006) 0.76

Two cases of hepatopulmonary syndrome with improved liver function following long-term oxygen therapy. J Gastroenterol (2007) 0.76

Abnormal Gas Diffusing Capacity and Portosystemic Shunt in Patients With Chronic Liver Disease. Gastroenterology Res (2012) 0.75

Hepatopulmonary syndrome: What we know and what we would like to know. World J Gastroenterol (2016) 0.75

Left Ventricular Dilation and Pulmonary Vasodilatation after Surgical Shunt for Treatment of Pre-Sinusoidal Portal Hypertension. PLoS One (2016) 0.75

CT Scan Does Not Differentiate Patients with Hepatopulmonary Syndrome from Other Patients with Liver Disease. PLoS One (2016) 0.75

Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis. Gut (1994) 0.75

Articles cited by this

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Porto-caval and porto-pulmonary anastomoses in Laennec's cirrhosis and in heart failure. J Clin Invest (1957) 2.86

Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis. Am J Med (1956) 2.76

Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med (1966) 2.65

Measurement of continuous distributions of ventilation-perfusion ratios: theory. J Appl Physiol (1974) 2.24

Reduction of intrapulmonary shunt and resolution of digital clubbing associated with primary biliary cirrhosis after liver transplantation. Hepatology (1990) 2.06

Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab (1979) 1.75

Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology (1988) 1.74

Measurements of capillary dimensions and blood volume in rapidly frozen lungs. J Appl Physiol (1969) 1.69

The lung in patients with cirrhosis. J Hepatol (1990) 1.59

Ventilation-perfusion inequality and overall gas exchange in computer models of the lung. Respir Physiol (1969) 1.56

Limits on VA/Q distributions from analysis of experimental inert gas elimination. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.52

Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis (1991) 1.44

Response of small pulmonary arteries to unilobar hypoxia and hypercapnia. Circ Res (1966) 1.42

An intravenous radionuclide method to evaluate hypoxemia caused by abnormal alveolar vessels. Limitation of conventional techniques. Am Rev Respir Dis (1976) 1.42

Multiple small arteriovenous fistulae of the lungs. Am J Pathol (1957) 1.39

Syndrome of cyanosis, digital clubbing, and hepatic disease in siblings. J Pediatr (1968) 1.30

Regional lung function in patients with hepatic cirrhosis. J Clin Invest (1971) 1.23

Venoarterial shunts in cirrhosis of the liver. Lancet (1960) 1.22

The endothelium--modulator of vascular smooth-muscle tone. N Engl J Med (1988) 1.21

Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation. Hepatology (1990) 1.17

Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis (1987) 1.17

Clinical relevance of ventilation-perfusion inequality determined by inert gas elimination. Eur Respir J (1990) 1.16

Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis. J Clin Invest (1972) 1.15

Alveolar-capillary oxygen disequilibrium in hepatic cirrhosis. Chest (1978) 1.12

Pulmonary circulatory dysfunction in rats with biliary cirrhosis. An animal model of the hepatopulmonary syndrome. Am Rev Respir Dis (1992) 1.12

Mottled chest radiograph and gas transfer defect in chronic liver disease. Thorax (1972) 1.08

Hepatogenic cyanosis: arteriovenous shunts in chronic active hepatitis. J Pediatr (1971) 1.05

Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate. Mayo Clin Proc (1987) 1.05

Pulmonary vascular tone improves VA/Q matching in obliterative pulmonary hypertension. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.04

Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver. Eur J Clin Invest (1987) 0.99

Severe hypoxemia and liver disease. Am Rev Respir Dis (1989) 0.98

Effect of lung volume and positional changes on pulmonary diffusing capacity and its components. J Appl Physiol (1985) (1991) 0.98

Normalization of ventilation/perfusion relationships after liver transplantation in patients with decompensated cirrhosis: evidence for a hepatopulmonary syndrome. Hepatology (1990) 0.96

Structural alterations to the pulmonary circulation in fulminant hepatic failure. Thorax (1979) 0.96

Severe hypoxemia-associated intrapulmonary shunt in a patient with chronic liver disease: improvement after medical treatment. Am Rev Respir Dis (1992) 0.92

Pulmonary and extrapulmonary contributors to hypoxemia in liver cirrhosis. Am Rev Respir Dis (1989) 0.90

Pulmonary hemodynamics and gas exchange during exercise in liver cirrhosis. Am Rev Respir Dis (1989) 0.89

Pulmonary aspects of liver disease and liver transplantation. Clin Chest Med (1989) 0.89

Ventilation-perfusion inequality in patients with non-alcoholic liver cirrhosis. Eur Respir J (1991) 0.88

Hypoxia and hydrothoraces in a case of liver cirrhosis: correlation of physiological, radiographic, scintigraphic, and pathological findings. Thorax (1977) 0.87

LUNG VOLUME, COMPLIANCE, AND ARTERIAL OXYGEN TENSIONS DURING CONTROLLED VENTILATION. J Appl Physiol (1964) 0.85

Cyanosis, clubbing and arterial oxygen unsaturation associated with Laennec's cirrhosis. Am J Med Sci (1959) 0.84

Hemodynamic disturbances and VA/Q matching in hypoxemic cirrhotic patients. Chest (1989) 0.84

Hypoxic pulmonary vasoconstriction in liver cirrhosis. Chest (1981) 0.83

Some aspects of circulatory disturbances in cirrhosis of the liver. Prog Liver Dis (1972) 0.81

[Disorders of respiration in patients before and after liver transplantation]. Respiration (1987) 0.80

Hepatopulmonary syndrome. Chest (1990) 0.78

Radionuclide demonstration of intrapulmonary shunting in cirrhosis. AJR Am J Roentgenol (1983) 0.78

Multiple microscopic pulmonary arteriovenous connections in the lungs presenting as cyanosis. Thorax (1985) 0.78

Is intrapulmonary arteriovenous shunting and hypoxemia a contraindication for liver transplantation? Hepatology (1991) 0.77

Effects of propranolol on arterial oxygenation and oxygen transport to tissues in patients with cirrhosis. Am Rev Respir Dis (1990) 0.77

The influence of cardiovascular function on gas exchange. Clin Chest Med (1983) 0.77

Articles by these authors

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut (2005) 10.95

Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 3.42

Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med (2001) 3.19

Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J (2006) 2.93

Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir (1986) 2.52

Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.30

Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J (2002) 2.19

[HIV infection declines among intravenous drug addicts in Barcelona: 1987-1993]. Med Clin (Barc) (1994) 2.04

Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax (2005) 1.92

Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol (2001) 1.89

Deep venous thrombosis and the risk of pulmonary embolism. A systematic study. Chest (1992) 1.79

Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J (1997) 1.79

Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol (1998) 1.79

Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J (2006) 1.76

Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study. Am J Respir Crit Care Med (1998) 1.74

Evidence of O2 supply-dependent VO2 max in the exercise-trained human quadriceps. J Appl Physiol (1985) (1999) 1.70

References values for forced spirometry. Group of the European Community Respiratory Health Survey. Eur Respir J (1998) 1.68

Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up. Eur Respir J (1994) 1.68

Pulmonary gas exchange response to oxygen breathing in acute lung injury. Am J Respir Crit Care Med (2000) 1.64

Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest (1988) 1.64

Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med (1992) 1.60

Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J (2008) 1.59

The lung in patients with cirrhosis. J Hepatol (1990) 1.59

Preventing asthma epidemics due to soybeans by dust-control measures. N Engl J Med (1993) 1.55

Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease. Eur Respir J (1996) 1.53

Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1994) 1.52

Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients. Eur Respir J (2003) 1.49

Total serum IgE is associated with asthma independently of specific IgE levels. The Spanish Group of the European Study of Asthma. Eur Respir J (1996) 1.48

Bacterial colonization as a potential source of nosocomial respiratory infections in two types of spirometer. Eur Respir J (1996) 1.48

Arterial oxygenation does not predict the outcome of patients with acute respiratory failure needing mechanical ventilation. Eur Respir J (1994) 1.47

Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD. Eur Respir J (2007) 1.45

Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis (1991) 1.44

Pulmonary ventilatory defects and occupational exposures in a population-based study in Spain. Spanish Group of the European Community Respiratory Health Survey. Am J Respir Crit Care Med (1998) 1.43

Infusion phlebitis in patients with acute pneumonia: a prospective study. Chest (1999) 1.43

Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax (2001) 1.42

Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.39

[Diagnostic approach to neoplasms at an internal medicine service]. Med Clin (Barc) (1996) 1.39

Undetected viral infection in diffuse alveolar damage associated with bone marrow transplantation. Eur Respir J (1996) 1.38

[Treatment of chronic obstructive pulmonary disease]. Rev Clin Esp (2001) 1.38

[The challenge of Web 2.0-based <<virtual ICU>>]. Med Intensiva (2009) 1.38

[The results of the operation of a monitoring unit for home oxygen therapy]. Arch Bronconeumol (1999) 1.38

[The polymerase chain reaction as a marker of cytomegalovirus infection in heart transplant recipients]. Med Clin (Barc) (1999) 1.38

Patients with obstructive sleep apnea exhibit genioglossus dysfunction that is normalized after treatment with continuous positive airway pressure. Am J Respir Crit Care Med (1999) 1.37

Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.33

Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.29

Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J (2003) 1.27

Mechanical ventilation in severe exacerbation of asthma. Study of 26 cases with six deaths. Eur J Respir Dis (1983) 1.26

Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am J Respir Crit Care Med (2001) 1.26

Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis (1989) 1.24

Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with chronic obstructive pulmonary disease. Quality of Life in COPD Study Group. J Clin Epidemiol (1998) 1.22

Genotype determination of hepatitis C virus from northern India: identification of a new subtype. J Med Virol (1996) 1.21

Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J (2000) 1.19

Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis (1987) 1.17

The burden of chronic disorders on hospital admissions prompts the need for new modalities of care: a cross-sectional analysis in a tertiary hospital. QJM (2009) 1.17

Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet (1996) 1.12

Sleep-related respiratory disturbances in patients with Duchenne muscular dystrophy. Eur Respir J (1994) 1.09

Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J (2002) 1.08

[Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease]. Arch Bronconeumol (2001) 1.06

Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.05

Risk factors of soybean epidemic asthma. The role of smoking and atopy. Am Rev Respir Dis (1992) 1.05

Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis. Am Rev Respir Dis (1986) 1.05

Mechanisms of gas exchange impairment in patients with liver cirrhosis. Clin Chest Med (1996) 1.04

Mechanisms of hypoxemia in patients with status asthmaticus requiring mechanical ventilation. Am Rev Respir Dis (1989) 1.04

Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.04

Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol (1999) 1.04

Asthma outbreaks in Barcelona. Lancet (1983) 1.03

Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J (1993) 1.03

Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1998) 1.02

Effects of F(I)O2 on leg VO2 during cycle ergometry in sedentary subjects. Med Sci Sports Exerc (1998) 1.01

Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax (1989) 1.01

Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients. Am Rev Respir Dis (1993) 1.01

Incidence and etiology of pneumonia acquired during mechanical ventilation. Crit Care Med (1989) 1.01

Long-term effects of nasal intermittent positive-pressure ventilation on pulmonary function and sleep architecture in patients with neuromuscular diseases. Chest (1996) 1.01

A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol (2003) 1.01

Novel display of knotted DNA molecules by two-dimensional gel electrophoresis. Nucleic Acids Res (2001) 1.00

Symbols, abbreviations and units. Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J Suppl (1993) 1.00

Opiates or cocaine: mortality from acute reactions in six major Spanish cities. State Information System on Drug Abuse (SEIT) Working Group. J Epidemiol Community Health (1995) 0.99

Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax (2008) 0.98

Ventilation-perfusion mismatch in patients with pleural effusion: effects of thoracentesis. Am J Respir Crit Care Med (1997) 0.97

Radiation, multiple dispersal and parallelism in the skinks, Chalcides and Sphenops (Squamata: Scincidae), with comments on Scincus and Scincopus and the age of the Sahara Desert. Mol Phylogenet Evol (2007) 0.97

Relationship between serum IgE and airway responsiveness in adults with asthma. J Allergy Clin Immunol (1995) 0.97

Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure. J Clin Invest (1996) 0.97

Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest (1990) 0.96

Ventilation-perfusion mismatch after methacholine challenge in patients with mild bronchial asthma. Am Rev Respir Dis (1991) 0.96

Importance of mitochondrial P(O2) in maximal O2 transport and utilization: a theoretical analysis. Respir Physiol Neurobiol (2013) 0.96

Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96

Prospective study of drug-resistant tuberculosis in a Spanish urban population including patients at risk for HIV infection. Eur J Clin Microbiol Infect Dis (1995) 0.95

Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy (2005) 0.95

Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology (1996) 0.95

Increase in pulmonary ventilation-perfusion inequality with age in healthy individuals. Am J Respir Crit Care Med (1997) 0.95

Value of chest radiography in phenotyping chronic obstructive pulmonary disease. Eur Respir J (2007) 0.95

Effects of altitude acclimatization on pulmonary gas exchange during exercise. J Appl Physiol (1985) (1989) 0.94

Another asthma outbreak in Barcelona: role of oxides of nitrogen. Lancet (1984) 0.93

Pulmonary gas exchange in severe chronic asthma. Response to 100% oxygen and salbutamol. Am Rev Respir Dis (1990) 0.93